| +974 4003 3333
Hani Bibawi

Hani Bibawi 
^ null
DClinSci,FRCPath,FIBMS

Consultant Clinical Scientist Years Of Experience: 20

  • About the Physician

    Dr. Hani Bibawi is a consultant clinical Scientist in Hematopathology. He joined Sidra Medicine in 2017. Prior to Sidra Medicine, Dr. Bibawi worked at the Haemto-Oncology Diagnostic Services (HODs) at Addenbrookes Hospital in Cambridge and the Department of Haematology at John Radcliffe Hospital in Oxford, UK.

    In his role as a consultant scientist, Dr. Bibawi is responsible for developing and reporting flow cytometry assays for routine diagnosis of leukemias, RBC disorders, and inherited platelet disorders.
    In addition to his clinical duties, Dr. Bibawi is very interested in medical education and collaborates as an adjunct assistant Professor of Haematology and Transfusion Medicine at Qatar University.

    Languages Spoken

    English, Arabic, Spanish

    Years Of Experience
    20
    Education
    • FRCPath: Fellowship of the Royal College of Pathologists, London, UK.
    • DClinSci: Doctorate of Clinical Sciences, University of Manchester M., UK.
    • HSST: Higher Specialist Scientist Training Program, Cambridge University Hospitals/University of Manchester (2015-2021).
    • Post Graduate Diploma in Leadership & Management in Healthcare Sciences, Manchester Business School, University of Manchester, UK (2017-2018).
    • Certificate in Total Laboratory Automation: University of Greenwich, London (July 2012)
    • Specialist Diploma in Haematology with Hospital Transfusion Practice: Institute of Biomedical Sciences (IBMS), London, UK (2010-2011)
    • Certificate in Quality Systems Management: University of Greenwich, London (July 2010)
    • MSc Hematology & Immune Haematology: University of Khartoum, Sudan (2006- 2008)
    • BSc (Hons 1st) Medical Laboratory Sciences: University of Khartoum, Sudan (1999-2003)
    Affiliations
    • College of Healthcare Sciences, Qatar University, Qatar
    • Royal College of Pathologists-RCPath (Haematology), UK
    • British Society for Haematology (BSH), UK
    • Health Profession Council (HCPC), UK
    • Fellow of the Institute of Biomedical Science (FIBMS), UK
    • OSFA Assessor at the National School of Healthcare Sciences (NSHCS), UK
    Areas of Interest
    • Leukaemia diagnosis
    • Flow Cytometry
    • Haemoglobinopathies
    • Coagulopathies
    • Medical education
    Medical Publications
    1. Acute GVHD is distinguished by an erythroid signature, Dec 2022
    2. Flow-Cytometry evaluation of Cellular Surface FVIII in Blood cells and its correlation with FVIII activity and coagulation (submitted to ASH, August 2021).
    3. Abstract: HLA-DR negative blast population in KMT2A-rearranged pediatric AML with monocytic phenotype (ESCCA, March 2021).
    4. Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasms. Br J Haematol. 2019 Apr;185(2):261-265.
    5. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. J Pathol. 2020 Mar;250(3):346-357.